BiOligo Biotechnology
- Headquarters
- Shanghai
- Employees
- 51–200
- Business Model
- B2B
- Website
- bioligo.com
- Last Round
- Series AOct 2021
- Rounds
- 1
About
Chinese biotechnology company specializing in oligonucleotide synthesis, gene synthesis, NGS services, and RNAi/CRISPR tools for life science research.
Summary
BiOligo Biotechnology is a Biotech company based in Shanghai, China. Its most recent funding was a Series A round in Oct 2021. Investors include The Carlyle Group.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.